TMX-2039
TMX-2039 is a pan-CDK inhibitor for both cell cycle CDKs (CDK1, CDK2, CDK4, CDK5 and CDK6) and transcriptional CDKs (CDK7 and CDK9), with IC50s of 2.6, 1.0, 52.1, 0.5, 35.0, 32.5 and 25 nM, respectively. TMX-2039 acts as a Ligands for Target Protein for PROTACs[1].
Product Specifications
CAS Number
2488892-01-7
UNSPSC
12352005
Target
CDK; Ligands for Target Protein for PROTAC
Related Pathways
Cell Cycle/DNA Damage; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
99.42
Smiles
CS(=O)(N1CCC(CC1)NC2=NC=C(C(NC3=CC=CC(F)=C3C(N)=O)=N2)Br)=O
Molecular Formula
C17H20BrFN6O3S
Molecular Weight
487.35
References & Citations
[1]Mingxing Teng, et al. Development of CDK2 and CDK5 Dual Degrader TMX-2172. Angew Chem Int Ed Engl. 2020 Aug 10;59 (33) :13865-13870.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK1; CDK2; CDK4; CDK5; CDK6; CDK7; CDK9
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Acid Phosphatase (ACP1) activation kit by CRISPRa
GRM7 Human Recombinant Protein, Synthetic Nanodisc
